Health Care Abbott Laboratories (ABT) Q3 2024 Earnings: Key financials and quarterly highlights 1 year ago Abbott Laboratories (NYSE: ABT) reported third quarter 2024 earnings results today. Total reported sales increased 4.9% year-over-year to $10.6 billion.… Key metrics from UnitedHealth Group’s (UNH) Q3 2024 earnings results 1 year ago UnitedHealth Group (NYSE: UNH) reported its third quarter 2024 earnings results today. Total revenues increased 9% year-over-year to $100.8 billion.… Johnson & Johnson (JNJ) Q3 2024 Earnings: Key financials and quarterly highlights 1 year ago Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings results today. Reported sales increased 5.2% year-over-year to $22.5 billion.… Earnings Preview: Johnson & Johnson bets on innovation to stay in growth mode 1 year ago Over the years, Johnson & Johnson (NYSE: JNJ) has remained a dominant player in the medical industry, benefitting from its… Walgreens Boots Alliance’s Q4 results likely to reflect market challenges 1 year ago Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been struggling to maintain sales momentum and profitability for quite some time due… TRxADE Health changes its name to Scienture Holdings 1 year ago Trxade Health, Inc. (NASDAQ: MEDS), a leading health services IT company, and its wholly owned subsidiary Scienture, LLC revealed that… IPO News: Everything you need to know about BioAge Labs’ IPO 1 year ago BioAge Labs, Inc. is the latest among the healthcare companies pursuing stock-market listing this year. In a registration statement filed… Guardian Pharmacy seeks to raise up to $108 mil in US IPO 1 year ago Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to… Everything you need to know about Zenas BioPharma’s IPO 1 year ago Zenas BioPharma, Inc. is among the latest healthcare companies to jump on the IPO bandwagon, filing its prospectus even as… Ocean Biomedical (NASDAQ: OCEA) Research Summary 1 year ago Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new therapeutic candidates efficiently from the laboratory… Next» « Previous